U.S. Markets closed

This Trial Failure Dropped Versartis Inc 86.6% and Lifted Ascendis Pharma 51.4%

newsfeedback@fool.com (Maxx Chatsko)
This Trial Failure Dropped Versartis Inc 86.6% and Lifted Ascendis Pharma 51.4%

One biopharma's loss is another biopharma's gain when it comes to rare disease drug trials.